196 related articles for article (PubMed ID: 21291492)
41. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1.
Deng T; Shan S; Li PP; Shen ZF; Lu XP; Cheng J; Ning ZQ
Endocrinology; 2006 Feb; 147(2):875-84. PubMed ID: 16269451
[TBL] [Abstract][Full Text] [Related]
42. Metabonomic profiling revealed an alteration in purine nucleotide metabolism associated with cardiac hypertrophy in rats treated with thiazolidinediones.
Liu Y; Yan X; Mao G; Fang L; Zhao B; Liu Y; Tang H; Wang N
J Proteome Res; 2013 Dec; 12(12):5634-41. PubMed ID: 24164426
[TBL] [Abstract][Full Text] [Related]
43. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
44. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Ai D; Fu Y; Guo D; Tanaka H; Wang N; Tang C; Hammock BD; Shyy JY; Zhu Y
Proc Natl Acad Sci U S A; 2007 May; 104(21):9018-23. PubMed ID: 17495027
[TBL] [Abstract][Full Text] [Related]
46. Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase.
Chen T; Jin X; Crawford BH; Cheng H; Saafir TB; Wagner MB; Yuan Z; Ding G
Free Radic Biol Med; 2012 Jul; 53(2):208-15. PubMed ID: 22609424
[TBL] [Abstract][Full Text] [Related]
47. Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation.
Shen Y; Wang X; Yuan R; Pan X; Yang X; Cai J; Li Y; Yin A; Xiao Q; Ji Q; Li Y; He B; Shen L
J Mol Cell Cardiol; 2021 Oct; 159():91-104. PubMed ID: 34147480
[TBL] [Abstract][Full Text] [Related]
48. SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy.
Shen T; Ding L; Ruan Y; Qin W; Lin Y; Xi C; Lu Y; Dou L; Zhu Y; Cao Y; Man Y; Bian Y; Wang S; Xiao C; Li J
Oxid Med Cell Longev; 2014; 2014():713894. PubMed ID: 25614777
[TBL] [Abstract][Full Text] [Related]
49. Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA
Am J Physiol Regul Integr Comp Physiol; 2016 Oct; 311(4):R676-R688. PubMed ID: 27488890
[TBL] [Abstract][Full Text] [Related]
50. The PPARγ agonist protects cardiomyocytes from oxidative stress and apoptosis via thioredoxin overexpression.
Kim YJ; Park KJ; Song JK; Shim TJ; Islam KN; Bae JW; Kim SM; Lee SY; Hwang KK; Kim DW; Cho MC; Ryu KH
Biosci Biotechnol Biochem; 2012; 76(12):2181-7. PubMed ID: 23221719
[TBL] [Abstract][Full Text] [Related]
51. Soluble epoxide hydrolase and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy: Interrelation and regulation by C/EBPβ.
Zhou Y; Wang XC; Wei JH; Xue HM; Sun WT; He GW; Yang Q
Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166643. PubMed ID: 36669577
[TBL] [Abstract][Full Text] [Related]
52. Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA
PLoS One; 2016; 11(9):e0162147. PubMed ID: 27583776
[TBL] [Abstract][Full Text] [Related]
53. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms.
Galli A; Ceni E; Crabb DW; Mello T; Salzano R; Grappone C; Milani S; Surrenti E; Surrenti C; Casini A
Gut; 2004 Nov; 53(11):1688-97. PubMed ID: 15479693
[TBL] [Abstract][Full Text] [Related]
54. Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and mice.
Morgan LA; Olzinski AR; Upson JJ; Zhao S; Wang T; Eisennagel SH; Hoang B; Tunstead JR; Marino JP; Willette RN; Jucker BM; Behm DJ
J Cardiovasc Pharmacol; 2013 Apr; 61(4):291-301. PubMed ID: 23232840
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
56. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
[TBL] [Abstract][Full Text] [Related]
57. PPARγ activation improves the molecular and functional components of I(to) remodeling by angiotensin II.
Nanayakkara G; Viswaprakash N; Zhong J; Kariharan T; Quindry J; Amin R
Curr Pharm Des; 2013; 19(27):4839-47. PubMed ID: 23323617
[TBL] [Abstract][Full Text] [Related]
58. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
59. Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
Imig JD; Walsh KA; Hye Khan MA; Nagasawa T; Cherian-Shaw M; Shaw SM; Hammock BD
Exp Biol Med (Maywood); 2012 Dec; 237(12):1402-12. PubMed ID: 23354399
[TBL] [Abstract][Full Text] [Related]
60. Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1.
Liu M; Ye J; Gao S; Fang W; Li H; Geng B; Zou J; Chen X; Chen S; Zhang L; Yue Z; Ma Y; Gao H; Li Z; Liu P
Biochem Biophys Res Commun; 2014 Feb; 444(3):346-53. PubMed ID: 24462865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
